Evidence map›Paper›PMID 23483280›Full record

ReviewMolecules and cells2013

Orai1-NFAT signalling pathway triggered by T cell receptor stimulation.

Sonal Srikanth, Yousang Gwack

Open access · greenAbstract readReview
In one paragraph

Review in Molecules and cells, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
5.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 96 citations in OpenAlex.

  1. Review
  2. Metal Ions Within the Neuro-Immune-Tumor Axis.Journal of immunology research · 2026
    Review
  3. Article
  4. A Model for the Coexistence of Competing Mechanisms forBulletin of mathematical biology · 2024
    Article
  5. Review
  6. Multifaceted control of T cell differentiation by STIM1.Trends in biochemical sciences · 2023
    Review
  7. A multiple-oscillator mechanism underlies antigen-induced CaThe Journal of biological chemistry · 2023
    Article
  8. Article
  9. Review
  10. Super resolution microscopy analysis reveals increased Orai1 activity in asthma and cystic fibrosis lungs.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Combination therapy of insulin-like growth factor I and BTP-2 markedly improves lipopolysaccharide-induced liver injury in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  15. The CaPharmaceutics · 2022
    Article
  16. CaJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  17. Article
  18. ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sonal SrikanthDepartment of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Yousang Gwack
University of California, Los Angeles · US

Funding

Novel regulators of store-operated Ca2+ entry in immune systemsR01AI083432 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GWACK, YOUSANG · 2009 to 2020
$3.8M
A new class of immunomodulator, CRAC channel blockersR21AI101569 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GWACK, YOUSANG · 2012 to 2013
$410k
NIAID NIH HHS AI-083432NIAID NIH HHS AI-101569NIAID NIH HHS R01 AI083432NIAID NIH HHS R21 AI101569
6 · The paper itself

Abstract

T cell receptor (TCR) stimulation plays a crucial role in development, homeostasis, proliferation, cell death, cytokine production, and differentiation of T cells. Thus, in depth understanding of TCR signalling is crucial for development of therapy targeting inflammatory diseases, improvement of vaccination efficiency, and cancer therapy utilizing T cell-based strategies. TCR activation turns on various signalling pathways, one of the important one being the Ca(2+)-calcineurin-nuclear factor of activated T cells (NFAT) signalling pathway. Stimulation of TCRs triggers depletion of intracellular Ca(2+) store and in turn, initiates store-operated Ca(2+) entry (SOCE), one of the major mechanisms to raise the intracellular Ca(2+) concentrations in T cells. Ca(2+)-release-activated-Ca(2+) (CRAC) channels are a prototype of store-operated Ca(2+) (SOC) channels in immune cells that are very well characterized. Recent identification of STIM1 as the endoplasmic reticulum (ER) Ca(2+) sensor and Orai1 as the pore subunit has dramatically advanced the understanding of CRAC channels and provides a molecular tool to investigate the physiological outcomes of Ca(2+) signalling during immune responses. In this review, we focus on our current understanding of CRAC channel activation, regulation, and downstream calcineurin-NFAT signaling pathway.

Indexed as

AnimalsCalcium ChannelsCalcium SignalingHumansLymphocyte ActivationNFATC Transcription FactorsORAI1 ProteinProtein Processing, Post-TranslationalReceptors, Antigen, T-CellT-LymphocytesCalcium ChannelsNFATC Transcription FactorsORAI1 ProteinORAI1 protein, humanReceptors, Antigen, T-Cell

Identifiers

PMID23483280
PMCPMC3887911
OpenAlexW2024902175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.